What Clinical Trial Participants Want — And How Sponsors can Deliver

What is the optimal clinical trial design? What do patients want when considering a clinical trial? The optimal trial design is not a one-size-fits-all approach. It is a series of countless permutations and protocol designs that must be carefully tailored to deliver the best trial for the patient and the sponsor.

In this webinar, Jon Meyer, Co-Founder of Life Science Strategy Group, will join Science 37’s Chief Strategy Officer, Drew Bustos to share survey results showing insights into what patients want with clinical trials now. Register now and discover:

• The technologies that have the greatest, and most positive impact on participants
• Which decentralized clinical trial elements are the top drivers of patient satisfaction
• Why flexibility, convenience and at-home options are a must in clinical trial design
• And, how to leverage an agile/hybrid approach to accelerate recruitment and improve patient diversity and retention

Speakers

Drew Bustos, Chief Strategy Officer, Science 37 (Moderator)

Drew Bustos is the Chief Strategy Officer of Science 37 and has led marketing teams for more than 15 years in a variety of large and nimble organizations. Drew previously held leadership roles at ERT and Quintiles (IQVIA), where he led product management for data offerings, headed corporate strategy/research, sizing, and market segmentation frameworks. Drew earned his B.A. in Business Administration from Fairleigh Dickinson University. He has successfully completed Executive programs at Stanford Graduate School of Business (LEAD: Corporate Innovation), the Wharton School of the University of Pennsylvania (Mini-MBA), and the Edwin L. Cox School of Business at SMU (Advanced Management).

Message Presenter

Jon Meyer, MSc, MBA, Co-Founder, Life Science Strategy Group, LLC

Jon Meyer, MSc, MBA is a Co-Founder and Managing Member of Life Science Strategy Group, LLC. For over 25 years, Mr. Meyer has managed strategic consulting engagements across all stages of the biopharmaceutical value chain including drug discovery, preclinical, clinical and commercial development and is the Biopharma Services Industry Consulting Practice Leader at LSSG. He has also consulted extensively with pharmaceutical and biotechnology clients in areas including dermatology, oncology, CNS, pain management and infectious disease, among other areas. His functional expertise includes strategic positioning, brand awareness and equity, opportunity assessments, pricing strategy, forecasting, competitive benchmarking, positioning and messaging strategy.

Message Presenter